4:02 PM
 | 
Dec 06, 2017
 |  BC Extra  |  Company News

Management Tracks: Sunesis, Vital

Cancer company Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS) said President and CEO Daniel Swisher will step down, effective Dec. 31. He will join Jazz Pharmaceuticals plc (NASDAQ:JAZZ) as president and COO. Director Dayton Misfeldt will serve as interim CEO while the company seeks a replacement.

Liver failure company Vital Therapies Inc. (NASDAQ:VTL) said CEO Terry Winters will step down, effective Jan. 3. Russell Cox, who is resigning as EVP and COO of Jazz on Jan. 3, will...

Read the full 351 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >